Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2–Tie2 complex
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
The Tie receptor tyrosine kinases and their angiopoietin (Ang) ligands play central roles in developmental and tumor-induced angiogenesis. Here we present the crystal structures of the Tie2 ligand-binding region alone and in complex with Ang2. In contrast to prediction, Tie2 contains not two but three immunoglobulin (Ig) domains, which fold together with the three epidermal growth factor domains into a compact, arrowhead-shaped structure. Ang2 binds at the tip of the arrowhead utilizing a lock-and-key mode of ligand recognition-unique for a receptor kinase-where two complementary surfaces interact with each other with no domain rearrangements and little conformational change in either molecule. Ang2-Tie2 recognition is similar to antibody-protein antigen recognition, including the location of the ligand-binding site within the Ig fold. Analysis of the structures and structure-based mutagenesis provide insight into the mechanism of receptor activation and support the hypothesis that all angiopoietins interact with Tie2 in a structurally similar manner.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, the previously identified TIE2 binding site in ANGPT2 FLD (16) is accessible in our ANGPT2147–496–α5Calf1-2 SAXS model.”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [16]
In the citing paper
“Interestingly, the model of the dimeric ANGPT2147–496 in complex with the inactive, half-bent α5β1-integrin and TIE2 ECDs could be created without steric clashes while maintaining the overall geometry and interactions of the existing structures found in this study and previously (13, 16, 54–56) (Figure 8, A and B, and Supplemental Video 2).”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [16]
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715 · cited 1×
“and refinement proceeded with molecular dynamics and energy minimization in CN”
BackgroundJones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 1×
“This arises as a result of two distinct processes termed vasculogenesis (formation of major primitive blood vessels) and angiogenesis (remodeling and extension of the adult vasculature”
BackgroundVascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · cited 1×
“dtd" [ ]> The development of the adult cardiovascular system involves the differentiation of endothelial cells from precursor angioblasts and their subsequent migration, growth and sproutin”
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81812-7 · Cited by 1,989
Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.-H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00963-7 · Cited by 1,227 · cited 1×
“or from ligand-induced conformational changes in the receptor that result in its dimerization (as in EGF”
BackgroundBlood Vessel Formation: What Is Its Molecular Basis?
Folkman, J., & D'Amore, P. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81810-3 · Cited by 1,215 · cited 1×
“dtd" [ ]> The development of the adult cardiovascular system involves the differentiation of endothelial cells from precursor angioblasts and their subsequent migration, growth and sproutin”
Cited by
Items 101–135 of 135
Aberrant Signaling Pathways: Hallmark of Cancer Cells and Target for Nanotherapeutics
Javan, G. T., Finley, S. J., Can, İ., Salhotra, A., Malhotra, A., & Soni, S. (2015) · Wiley eBooks · doi:10.1002/9781118998922.ch1 · Cited by 3
Tie Receptor Signaling in Cardiac Lymphangiogenesis
Qu, X., & Baldwin, H. S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6774-8_8 · Cited by 2
“Crystal structure analyses reveal that the ligands Ang1 and Ang2 bind with almost similar affi nity to the same site (the second Ig motif) of the Tie2 receptor [ 27 , 28 ].”
BackgroundQutaina, S., Haitian, Z. H. A. O., Wang, Z., Ivaldo, C., Ruiz, S., Sullivan, A., Murphy, E., & Marambaud, P. (2026) · Blood Vessels Thrombosis & Hemostasis · doi:10.1016/j.bvth.2026.100155 · Cited by 2
“ANG2 can act as either an agonist or antagonist of Tie2, depending on the physiological context, and is often associated with EC destabilization and vascular activation.”
Zeifman, A. A., Челышева, Е. Ю., Tukrina, A. G., & Chilov, G. G. (2014) · Clinical oncohematology · doi:10.21320/2500-2139-2014-7-1-16-27 · Cited by 2
Li, H., Wang, R., Xu, P., Yuan, C., Huang, M., & Jiang, L. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150484 · Cited by 1
The Significance of Angiopoietin Valency in Vascular Health and Disease
Zhao, Y. T., Ehnes, D. D., Mathieu, J., & Ruohola‐Baker, H. (2026) · Cells · doi:10.3390/cells15090820 · Cited by 3
“The LBD comprises three Ig-like domains (Ig1, Ig2, and Ig3) and three EGF-like domains [58] (Figure 1).”
Landscape and Targeting of the Angpt-Tie System in Current Anticancer Therapy
Sun, L., & Zhang, B. (2015) · Translational Medicine · doi:10.4172/2161-1025.1000157 · Cited by 2
“Due to the multimeric nature of Angpt1 and Angpt2, the Tie2 receptor is likely to function as oligomers, as well [16].”
BackgroundDirect contribution of angiogenic factors to neurodevelopment: a focus on angiopoietins
Luck, R., Karakatsani, A., & de Almodóvar, C. R. (2020) · e-Neuroforum · doi:10.1515/nf-2020-0025 · Cited by 2
Gibson, J. M., Fenner, R. B., Long, G. L., Borland, M. D., & Decker, G. A. (2007) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · doi:10.2172/962874 · Cited by 1
Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling
Sipilä, T., Ponna, S. K., Venkatesha Murthy, A., Pink, A., Enkavi, G., Bohra, S. K., Lewna, K., Ganesh, K., Liu, Q., Korhonen, M., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci190552
Protein Kinase Structure, Function, and Regulation
Matthews, D. J., & Gerritsen, M. E. (2010) · Wiley eBooks · doi:10.1002/9780470555293.ch2
Regulation of EGF receptor dynamics by protein tyrosine phosphatases
Monast, C. S. (2013) · ScholarlyCommons (University of Pennsylvania)
TIE1 (tyrosine kinase with immunoglobulin-like and EGF-like domains 1)
Saharinen, P. (2012) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/47491
The Role of Angiopoietin-2 in Signaling Through the Endothelial Receptor Tyrosine Kinase Tie1
Otvos, B. I. (2010) · DukeSpace (Duke University)
Ng, T. K. (2014) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000098
The Tie2 RTK : regulation and downstream signaling.
Sturk, C. (2010) · TSpace (University of Toronto)
Characterization of Tie2 signalling during acute inflammation
Smith, T. L. (2018) · TSpace (University of Toronto)
Hakanpää, L. (2020) · Helda - University of Helsinki Institutional Repository
Brunckhorst, M. K., Wang, H., Lu, R., & Yu, Q. (2023) · doi:10.1158/0008-5472.c.6500714
VEGFR-3 and Tie pathways in vascular network formation
Tammela, T. (2008) · Työväentutkimus Vuosikirja
Kumar, S., Li, Z., Tan, J., Cheng, Y., Wang, X., Fernandes, C., Zhong, K., Kain, K. C., & Ruda, H. E. (2026) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2026.100956
In-silico evaluation of molecular docking of new triazole derivatives as antiproliferative activity
Hussein, N. R., Sahib, H. B., & Omran, Z. S. (2026) · Chirurgia · doi:10.23736/s0394-9508.25.05901-7
Lebrun, A. (2011) · theses.fr (ABES) · doi:10.70675/c897c7acz9b33z4feez8d9dza982db69ef95 · Cited by 1
Tie1 et la transition endothélio-mésenchymateuse
Garcia, J. (2013) · theses.fr (ABES) · doi:10.70675/063d32edz5c5cz44e7zb912z0fa2bc96180b
Al‐Akhrass, H. (2017) · theses.fr (ABES) · doi:10.70675/e9c14c3dz3db4z468fzacdez756df2262726
Etude et inhibition de l'activation endothéliale au cours de l'angiogenèse
Cossutta, M. (2017) · theses.fr (ABES) · doi:10.70675/b2ab1c80zb5caz47c4za53bz83c66b494fda · Cited by 1
Liabotis, A. (2018) · theses.fr (ABES) · doi:10.70675/52bcdc87z9aedz40abz9459z9019f91b56fe
Saccone, M. A. (2019) · theses.fr (ABES) · doi:10.70675/d8995276z6866z4372zbbc2z271914e8a438
Integrin-independent Tie2 activation using de novo designed proteinsPreprint
McCurdy, C., Zhao, Y. T., Kumar, S., Coventry, B., Pink, A., Fu, Y., Bohn, P., Zhu, S., Goreshnik, I., Wang, X., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.01.718274
Modeling Permittivity in Proteins: A User-Friendly Approach
Alfinito, E., & Beccaria, M. (2026) · Chemosensors · doi:10.3390/chemosensors14100222
Pathogenesis and molecular mechanisms of mutant TIE2-driven venous malformation
Bischoff, L. J., & Boscolo, E. (2026) · Angiogenesis · doi:10.1007/s10456-026-10088-y
“Its extra-cellular portion, which is responsible for ligand binding, consists of three immunoglobulin (Ig) domains, three epi - dermal growth factor (EGF) repeats, and three fibronectin (FN) type III repeats [126].”
Targeting receptor tyrosine kinases: from molecular mechanisms to clinical therapeutics
Wu, K., Ji, J., Sun, T., Lv, D., Pan, J., Wei, M., Zhu, M., Wang, M., Li, L., & Yao, H. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02840-z
“49 Notably, other RTK subfamilies, such as Eph receptors 50 and TIE2, 27 can form preassembled oligomeric clusters at the plasma membrane.”
Engineering Novel Angiopoietin Receptor Ligands
Moss, A. (2011) · Figshare
Metadata
- Authors
- Barton, W. A., Tzvetkova-Robev, D., Miranda, E. P., Kolev, M. V., Rajashankar, K. R., Himanen, J. P., & Nikolov, D. B.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Nikolov, Dimitar B
- Venue
- Nature Structural & Molecular Biology
- Published
- 2006-05-28
- Volume
- 13
- Issue
- 6
- Pages
- 524-532
- ISSN
- 1545-9985 (ISSN-L)
- 1545-9993
- OpenAlex
- W2100589229
- Cited by
- 134
- References
- 51
- Citations by year
- 2026: 9 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 11 · 2020: 4 · 2019: 8 · 2018: 4 · 2017: 9 · 2016: 6 · 2015: 8 · 2014: 9 · 2013: 12 · 2012: 7
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Structural & Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R01HL077249)
- National Center for Research Resources (RR 15301, P41RR015301)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- Tie2 receptor, angiopoietin-2, receptor tyrosine kinase, ligand-binding domain, immunoglobulin domains, epidermal growth factor domain, receptor activation mechanism, angiogenesis, structure-guided mutagenesis
- MeSH terms
- Amino Acid Sequence, Calcium, Chromatography, Gel, Epidermal Growth Factor, Fibrinogen, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Conformation, Sequence Homology, Amino Acid, Crystallography, X-Ray, Angiopoietin-2, Receptor, TIE-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.